BioTelemetry, Inc. (NASDAQ: BEAT) received the Food and Drug Administration's approval for its next generation Mobile Cardiac Outpatient Telemetry device, the MCOT Patch. According to the company, the ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback